Cavallin-Ståhl, E <br/><br/>
Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.  [electronic resource] 

 -  Seminars in oncology  Mar 1986 
 - 19-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chlorambucil--analogs & derivatives<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Humans<br/>Lymphoma--drug therapy<br/>Male<br/>Middle Aged<br/>Prednimustine--adverse effects<br/>Prednisone--adverse effects<br/>Sweden<br/>Vincristine--adverse effects